RT @ABfromthelab: If you are interested in the role of LAT1-mediated metabolism in cancer, also check recent @CRUK_BI work from @malviya_gl…
RT @ABfromthelab: If you are interested in the role of LAT1-mediated metabolism in cancer, also check recent @CRUK_BI work from @malviya_gl…
RT @ABfromthelab: If you are interested in the role of LAT1-mediated metabolism in cancer, also check recent @CRUK_BI work from @malviya_gl…
RT @ABfromthelab: If you are interested in the role of LAT1-mediated metabolism in cancer, also check recent @CRUK_BI work from @malviya_gl…
If you are interested in the role of LAT1-mediated metabolism in cancer, also check recent @CRUK_BI work from @malviya_glasgow, @PatelRach @DavidYLewis and @HingLeung4 ; as well as this masterpiece from @RafaPhD and @owen_sansom : https://t.co/jjClcevL8Y
New from #CR_UK https://t.co/xztVRqiTyq 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy.
RT @malviya_glasgow: Happy to share our paper.. Out today in #EJNMMI_Res! Showing..18F-Fluciclovine PET/MR highlighted tumour heterogeneit…
RT @malviya_glasgow: Happy to share our paper.. Out today in #EJNMMI_Res! Showing..18F-Fluciclovine PET/MR highlighted tumour heterogeneit…
Congratulations @DavidYLewis @malviya_glasgow @HingLeung4 @PatelRach
RT @malviya_glasgow: Happy to share our paper.. Out today in #EJNMMI_Res! Showing..18F-Fluciclovine PET/MR highlighted tumour heterogeneit…
RT @CRUK_BI: Congratulations Gaurav and everyone involved @CRUK_BI, @UofGCancerSci and @NHSResearchScot. https://t.co/T7h3Zq3oZS
RT @malviya_glasgow: Happy to share our paper.. Out today in #EJNMMI_Res! Showing..18F-Fluciclovine PET/MR highlighted tumour heterogeneit…
Congratulations Gaurav and everyone involved @CRUK_BI, @UofGCancerSci and @NHSResearchScot.
Happy to share our paper.. Out today in #EJNMMI_Res! Showing..18F-Fluciclovine PET/MR highlighted tumour heterogeneity & therapy resistance. It's open access @ https://t.co/U8ysQuTf7a Congratulation! @HingLeung4 @DavidYLewis @PatelRach @CR_UK @CRUK_
New article: 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. https://t.co/FBCT6gdedg #prostatecancer #oncology https://t.co/L4xjLSTu7k